References
- van Roon J H, Haex A JC, Seeder W A, de Jong J. Chemical and biochemical analysis of gluten toxicity. II. Gastroenterologica 1960; 94: 227
- Frazer A C, Fletcher R F, Ross C AC, Shaw B, Sammons H G, Schneider R. Gluten-induced enteropathy. The effect of partially digested gluten. Lancet 1959; 2: 252
- Howdle P D, Ciclitira P J, Simpson F G, Losowsky MS. Are all gliadins toxic in coeliac disease?. Scand J Gastroenterol 1984; 19: 41
- Ciclitira P, Evans D, Fagg N, Lennox E, Dowling R. Clinical testing of gliadin fractions in coeliac patients. Clin Sci 1984; 66: 357–64
- Kasarda D D, Tw Okita, Bernadin J E, Backer P A, Nimmo C, Lew E, et al. Nucleic acid (cDNA) and amino acid sequences of wtype gliadins from wheat (Triricum aesriuurn). Proc Natl Acad Sci 1984; 81: 4712
- Devery J M, Bender V, Penttila I, Skerritt JH. Identification of reactive synthetic gliadin peptides specific for coeliac disease. Int Arch All Appl Immunol 1991; 95: 356
- Gjertsen H A, Sollid L M, Thorsby E, Lundin KE. T cells from the peripheral blood of coeliac disease patients recognize gluten antigens when presented by HLA-DR, DQ, or -DP molecules. Scand J Immunol 1994; 39: 567
- Wieser H, Belitz H-D, Ashkenazi A, Idar D. Isolation of coeliac active peptide fractions from gliadin. Z Lebensm Unters Forsch 1983; 176: 85
- Wieser H, Belitz H-D, Ashkenazi A. Amino acid sequence of the coeliac active ghadin peptide B3142. Z Lebensm Unters Forsch 1984; 179: 371
- Wieser H, Belitz H-D, Idar D, Ashkenazi A. Coeliac activity of gliadin peptides CT-1 and CT-2. Z. Lebensm Unters Forsch 1986; 182: 115
- de Ritis G, Auricchio S, Jones H W, Lew EJ-L, Bernadin J E, Kasarda DD. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease. Gastroenterology 1988; 94: 41
- Kagnoff M F, Raleigh K A, Hubert J J, Bernadin J F, Kasarda DD. Possible role of a human adenovirus in the pathogenesis of coeliac disease. J Exp Med 1984; 160: 1544
- Karagiannis J, Priddle J, Jewell D. Cell-mediated immunity to a synthetic gliadin peptide resembling a sequence from adenovirus 12. Lancet 1987; 1: 884
- Mantzaris G, Karagiannis J, Priddle J, Jewell DP. Cellular hypersensitivity to a synthetic dodecapeptide derived from human adenovirus 12 which resembles a sequence of A-gliadin in patients with coeliac disease. Gut 1990; 31: 668
- Mantzaris G, Jewell D. In vivo toxicity of a synthetic dodecapeptide from A-gliadin in patients with coeliac disease. Scand J Gastroenterol 1991; 26: 392
- Browning T, Trier J. Organ culture of mucosal biopsies of human small intestine. J Clin Invest 1969; 48: 1423
- Falchuk Z M, Gebhard R L, Sessoms C, Strober W. An in vitro model of gluten sensitive enteropathy. Effect of gliadin on intestinal epithelial cells of patients with gluten sensitive enteropathy in organ culture. J Clin Invest 1974; 53: 487
- Jos J, de Tand M-F, Arnaud-Battandier F, Boissel J P, Popineau Y, Wajcman H. Separation of pure toxic peptides from a /S-gliadin subfraction using high performance liquid chroma-tography. Clin Chim Acta 1983; 134: 189
- Howdle PD. Organ culture of gastrointestinal mucosa—a technique for the study of the human gastrointestinal tract. Postgrad Med J 1984; 60: 645
- Meeuwisse G. Diagnostic criteria in coeliac disease. Acta Pae-diatr Scand 1970; 59: 461
- Walker-Smith J, Guandalini S, Schmitz J, Shmerling D, Visakorpi J. Revised criteria for diagnosis of coeliac disease. Arch Dis Child 1990; 65: 909
- Howdle P D, Corazza G R, Bullen A W, Losowsky MS. Gluten sensitivity of small intestinal mucosa in vitro: quantitative assessment of histologic change. Gastroenterology 1981; 80: 442
- Jos J, Lenoir G, de Ritis G, Rey J. In vitro culturing of biopsies from children. Coeliac disease, WM TJ Hekkene, A S Pena. Stenfert Kroese, Leiden 1974; 91–105
- Fluge O, Sletten K, Fluge G, Aksnes L, Elsayed S. In vitro toxicity of purified gluten peptides tested by organ culture. J Paediatr Gastro Nutr 1994; 18: 186–92
- Tatham A S, Marsh M N, Wieser H, Shewry PR. Conformational studies of peptides corresponding to the coeliac-activating regions of wheat wgliadin. Biochem J 1990; 270: 313
- Brown J H, Jardetsky T S, Gorga J C, Stern L J, Urban R G, Strominger J L, et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993; 364: 33
- Auricchio S, de Ritis G, Maiuri L, Mayer M, Pavone V, Lom-Bardi A, et al. A-gliadin related synthetic peptides: damaging effects on in vitro cultured atrophic celiac intestinal mucosa and developing fetal rat intestine. Gastroenterology 1991; 100: A194
- Ellis H J, Doyle A P, Wieser H, Sturgess R P, Ciclitira PJ. Specificities of monoclonal antibodies to domain I of a-gliadins. Scand J Gastroenterol 1993; 28: 212
- Sturgess R, Day P, Ellis J, Lundin K EA, Gjertsen H A, Kon-Takou M, et al. Sequenced gliadin oligopeptide challenge in coeliac disease. Lancet 1994; 343: 758
- Fluge G, Asknes L. Morphological and morphometric assessment of human duodenal biopsies maintained in organ culture. Scand J Gastroenterol 1981; 16: 555